Therapeutic effects of 3,3′-diindolylmethane on the alveolar bone in mice with experimentally induced periodontitis

References

• Kara A, Akman S, Ozkanlar S, et al. Immune modulatory and antioxidant effects of melatonin in experimental periodontitis in rats. Free Radic Biol Med. 2013;55(1):21–26.
   PubMedGoogle Scholar
• Morand DN, Davideau JL, Clauss F, et al. Cytokines during periodontal wound healing: potential application for new therapeutic approach. Oral Dis. 2017;23(3):300–311.
   PubMed Web of Science ®Google Scholar
• Kim YH, Kwon HS, Kim DH, et al. 3,3′-diindolylmethane attenuates colonic inflammation and tumorigenesis in mice. Inflammatory Bowel Dis. 2009;15(8):1164–1173.
   PubMed Web of Science ®Google Scholar
• Rouse M, Rao R, Nagarkatti M, et al. 3,3′-diindolylmethane ameliorates experimental autoimmune encephalomyelitis by promoting cell cycle arrest and apoptosis in activated T cells through microRNA signaling pathways. J Pharmacol Exp Ther. 2014;350(2):341–352.
   PubMed Web of Science ®Google Scholar
• Kim EJ, Park H, Kim J, et al. 3,3′-diindolylmethane suppresses 12-O-tetradecanoylphorbol-13-acetate-induced inflammation and tumor promotion in mouse skin via the downregulation of inflammatory mediators. Mol Carcinog. 2010;49(7):672–683.
   PubMed Web of Science ®Google Scholar
• Yu TY, Pang WJ, Yang GS. 3,3′-Diindolylmethane increases bone mass by suppressing osteoclastic bone resorption in mice. J Pharmacol Sci. 2015;127(1):75–82.
   PubMed Web of Science ®Google Scholar
• Xue L, Pestka JJ, Li M, et al. 3,3′-Diindolylmethane stimulates murine immune function in vitro and in vivo. J Nutr Biochem. 2008;19(5):336–344.
   PubMed Web of Science ®Google Scholar
• Benson JM, Shepherd DM. Dietary ligands of the aryl hydrocarbon receptor induce anti-inflammatory and immunoregulatory effects on murine dendritic cells. Toxicol Sci. 2011;124(2):327–338.
   PubMed Web of Science ®Google Scholar
• Liu Y, She W, Wang F, et al. 3,3′-diindolylmethane alleviates steatosis and the progression of NASH partly through shifting the imbalance of Treg/Th17 cells to Treg dominance. Int Immunopharmacol. 2014;23(2):489–498.
   PubMed Web of Science ®Google Scholar
• Kilkenny C, Browne WJ, Cuthill IC, et al. Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. Osteoarthr Cartil. 2012;20(4):256–260.
   PubMed Web of Science ®Google Scholar
• Abe T, Hajishengallis G. Optimization of the ligature-induced periodontitis model in mice. J Immunol Methods. 2013;394(1-2):49–54.
   PubMed Web of Science ®Google Scholar
• de Molon RS, de Avila ED, Boas Nogueira AV, et al. Evaluation of the host response in various models of induced periodontal disease in mice. J Periodontol. 2014;85(3):465–477.
   PubMed Web of Science ®Google Scholar
• Bainbridge B, Verma RK, Eastman C, et al. Role of porphyromonas gingivalis phosphoserine phosphatase enzyme SerB in Inflammation, immune response, and induction of alveolar bone resorption in rats. Infect Immun. 2010;78(11):4560–4569.
   PubMed Web of Science ®Google Scholar
• Leitão RF, Ribeiro RA, Chaves HV, et al. Nitric oxide synthase inhibition prevents alveolar bone resorption in experimental periodontitis in rats. J Periodontol. 2005;76(6):956–963.
   PubMed Web of Science ®Google Scholar
• Dong Y, Huihui Z, Li C. Piperine inhibit inflammation, alveolar bone loss and collagen fibers breakdown in a rat periodontitis model. J Periodont Res. 2015;50(6):758–765.
   PubMed Web of Science ®Google Scholar
• Zhang W, Ju J, Rigney T, et al. Porphyromonas gingivalis infection increases osteoclastic bone resorption and osteoblastic bone formation in a periodontitis mouse model. BMC Oral Health. 2014;14(1):89–97.
   PubMedGoogle Scholar
• Carvalho RS. Effect of venlafaxine on bone loss associated with ligature-induced periodontitis in Wistar rats. J Negat Results Biomed. 2010;9(1):1–8.
   PubMedGoogle Scholar
• Arabaci T, Kermen E, zkanlar S, et al. Therapeutic effects of melatonin on alveolar bone resorption after experimental periodontitis in rats. A Biochemical and Immunohistochemical Study. J Periodontol. 2015;86(7):874–881.
   PubMed Web of Science ®Google Scholar
• Li CH, Amar S. Morphometric, histomorphometric, and microcomputed tomographic analysis of periodontal inflammatory lesions in a murine model. J Periodontol. 2007;78(6):1120–1128.
   PubMed Web of Science ®Google Scholar
• Chakravarti A, Raquil MA, Tessier P, et al. Surface RANKL of Toll-like receptor 4-stimulated human neutrophils activates osteoclastic bone resorption. Blood. 2009;114(8):1633–1644.
   PubMed Web of Science ®Google Scholar
• Yamashita T, Takahashi N, Udagawa N. New roles of osteoblasts involved in osteoclast differentiation. World J Orthop. 2012;3(11):175–181.
   PubMedGoogle Scholar
• Crotti T, Smith MD, Hirsch R, et al. Receptor activator NF κB ligand (RANKL) and osteoprotegerin (OPG) protein expression in periodontitis. J Periodontal Res. 2003;38(4):380–387.
   PubMed Web of Science ®Google Scholar
• Liu D, Xu JK, Figliomeni L, et al. Expression of RANKL and OPG mRNA in periodontal disease: possible involvement in bone destruction. Int J Mol Med. 2003;11(1):17–21.
   PubMed Web of Science ®Google Scholar
• Mahamed DA, Marleau A, Alnaeeli M, et al. G(−) anaerobes-reactive CD4+ T-cells trigger RANKL-mediated enhanced alveolar bone loss in diabetic NOD mice. Diabetes. 2005;54(54):1477–1486.
   PubMedGoogle Scholar
• Dong L, Xia S, Gao F, et al. 3,3′-Diindolylmethane attenuates experimental arthritis and osteoclastogenesis. Biochem Pharmacol. 2010;79(79):715–721.
   PubMedGoogle Scholar
• Cochran DL. Inflammation and bone loss in periodontal disease. J Periodontol. 2008;79(8 Suppl):1569–1576.
   PubMed Web of Science ®Google Scholar
• Kim EK, Kim YS, Milner JA, et al. Indole-3-carbinol and 3,3′-diindolylmethane modulate androgen's effect on C-C chemokine ligand 2 and monocyte attraction to prostate cancer cells. Cancer Prev Res. 2013;6(6):519–529.
   PubMed Web of Science ®Google Scholar